EPO and myelodysplastic syndrome: While PRT4165 further increased erythropoietin-induced erythroid differentiation in healthy bone marrow cells, the influence of erythropoietin was severely impaired in MDS cells and not further affected by PRT4165 (Figure 5B and 5C) likely reflecting the complex differentiation defect, which is a hallmark of MDS.